These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction. Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Steg PG; Wiviott SD; Mauri L; J Am Coll Cardiol; 2016 May; 67(21):2492-502. PubMed ID: 27046159 [TBL] [Abstract][Full Text] [Related]
5. Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L; JAMA; 2015 Mar; 313(11):1113-21. PubMed ID: 25781440 [TBL] [Abstract][Full Text] [Related]
6. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study. Resor CD; Nathan A; Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Gabriel Steg P; Hsieh WH; Mauri L; Circulation; 2016 Oct; 134(14):989-998. PubMed ID: 27576774 [TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. Yeh RW; Secemsky EA; Kereiakes DJ; Normand SL; Gershlick AH; Cohen DJ; Spertus JA; Steg PG; Cutlip DE; Rinaldi MJ; Camenzind E; Wijns W; Apruzzese PK; Song Y; Massaro JM; Mauri L; JAMA; 2016 Apr; 315(16):1735-49. PubMed ID: 27022822 [TBL] [Abstract][Full Text] [Related]
8. Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy). Stefanescu Schmidt AC; Kereiakes DJ; Cutlip DE; Yeh RW; D'Agostino RB; Massaro JM; Hsieh WH; Mauri L; Circulation; 2017 May; 135(18):1720-1732. PubMed ID: 28228427 [TBL] [Abstract][Full Text] [Related]
9. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. Yeh RW; Kereiakes DJ; Steg PG; Windecker S; Rinaldi MJ; Gershlick AH; Cutlip DE; Cohen DJ; Tanguay JF; Jacobs A; Wiviott SD; Massaro JM; Iancu AC; Mauri L; J Am Coll Cardiol; 2015 May; 65(20):2211-21. PubMed ID: 25787199 [TBL] [Abstract][Full Text] [Related]
10. Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement. Garratt KN; Weaver WD; Jenkins RG; Pow TK; Mauri L; Kereiakes DJ; Winters KJ; Christen T; Allocco DJ; Lee DP Circulation; 2015 Jan; 131(1):62-73. PubMed ID: 25400062 [TBL] [Abstract][Full Text] [Related]
11. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy. Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L; JACC Cardiovasc Interv; 2015 Oct; 8(12):1552-62. PubMed ID: 26493248 [TBL] [Abstract][Full Text] [Related]
12. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial. Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T; JAMA; 2019 Jun; 321(24):2414-2427. PubMed ID: 31237644 [TBL] [Abstract][Full Text] [Related]
13. Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies. Yoshikawa Y; Shiomi H; Watanabe H; Natsuaki M; Kondo H; Tamura T; Nakagawa Y; Morimoto T; Kimura T Circulation; 2018 Feb; 137(6):551-562. PubMed ID: 28982692 [TBL] [Abstract][Full Text] [Related]
14. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. Mauri L; Kereiakes DJ; Yeh RW; Driscoll-Shempp P; Cutlip DE; Steg PG; Normand SL; Braunwald E; Wiviott SD; Cohen DJ; Holmes DR; Krucoff MW; Hermiller J; Dauerman HL; Simon DI; Kandzari DE; Garratt KN; Lee DP; Pow TK; Ver Lee P; Rinaldi MJ; Massaro JM; N Engl J Med; 2014 Dec; 371(23):2155-66. PubMed ID: 25399658 [TBL] [Abstract][Full Text] [Related]
15. Causes of late mortality with dual antiplatelet therapy after coronary stents. Mauri L; Elmariah S; Yeh RW; Cutlip DE; Steg PG; Windecker S; Wiviott SD; Cohen DJ; Massaro JM; D'Agostino RB; Braunwald E; Kereiakes DJ; Eur Heart J; 2016 Jan; 37(4):378-85. PubMed ID: 26586780 [TBL] [Abstract][Full Text] [Related]
16. Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. Yeh RW; Kereiakes DJ; Steg PG; Cutlip DE; Croce KJ; Massaro JM; Mauri L; J Am Coll Cardiol; 2017 Oct; 70(18):2213-2223. PubMed ID: 29073947 [TBL] [Abstract][Full Text] [Related]
17. Benefit and Risk of Prolonged DAPT After Coronary Stenting in Women. Berry NC; Kereiakes DJ; Yeh RW; Steg PG; Cutlip DE; Jacobs AK; Abbott JD; Hsieh WH; Massaro JM; Mauri L; Circ Cardiovasc Interv; 2018 Aug; 11(8):e005308. PubMed ID: 30354781 [TBL] [Abstract][Full Text] [Related]
18. Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Brener SJ; Kirtane AJ; Rinaldi MJ; Stuckey TD; Witzenbichler B; Weisz G; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Brodie BR; Mehran R; McAndrew T; Stone GW Circ Cardiovasc Interv; 2018 Oct; 11(10):e006853. PubMed ID: 30354629 [TBL] [Abstract][Full Text] [Related]
19. Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial. Kim BK; Hong SJ; Cho YH; Yun KH; Kim YH; Suh Y; Cho JY; Her AY; Cho S; Jeon DW; Yoo SY; Cho DK; Hong BK; Kwon H; Ahn CM; Shin DH; Nam CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y; JAMA; 2020 Jun; 323(23):2407-2416. PubMed ID: 32543684 [TBL] [Abstract][Full Text] [Related]